FOLH1 and posterior cortical atrophy: Taken together, PSMA expression studies in dogs with PCA highlight the potential use of PSMA-directed theragnostics, and through a comparative oncology lens, the dog may help bridge the gap between preclinical modeling and human clinical trials for these technologies.